Lv31
270 积分 2024-09-09 加入
Didymin ameliorates ulcerative colitis-associated secondary liver damage by facilitating Notch1 degradation
1个月前
已完结
1, 2‐trans‐Stereoselective 7‐O‐Glycosylation of Flavonoids with Unprotected Pyranoses by Mitsunobu Reaction
2个月前
已完结
Abstract 5457: QLH11811, a selective 4th-generation EGFR inhibitor for osimertinib-resistant EGFR-mutant NSCLC
3个月前
已关闭
Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer
3个月前
已完结
Orthoallosteric EGFR‐TKIs: A New Paradigm in NSCLC Treatment Strategy Targeting the C797S Mutation
3个月前
已关闭
Synthesis, activity, and their relationships of 2,4-diaminonicotinamide derivatives as EGFR inhibitors targeting C797S mutation
3个月前
已完结
Global burden and trends of lung cancer incidence and mortality
4个月前
已完结
Befotertinib—a viable alternative in EGFR-mutant advanced NSCLC?
4个月前
已完结
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study
4个月前
已完结
Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung Cancer
5个月前
已完结
皖公网安备34019202002308
